+34 620 10 75 37info@nanbiosis.com

News U8

Pablo Laguna and Jordi Aguilo, Scientific Directors of the Units 27 and 8 of NANBIOSIS participate in the European program Remote Assessment of Disease and Relapse in Central Nervous System Disorders (RADAR-CNS)

RADAR-CNS is an important European research program supported by the Innovative Medicines Initiative (IMI) focused to develop new ways of monitoring patients affected by major depression, epilepsy and multiple sclerosis, with the use of wearable technology and smart mobile phones.

This program brings together experts from various disciplines in clinical research, engineering, computer and data analysis, as well as health services. RADAR-CN aims to improve symptoms and quality of life of patients and treatment of these and other chronic diseases. This program is jointly led by King’s College London and the pharmaceutical company Janssen and is funded by the Innovative Medicines Initiative (a public-private agreement EFPIA and the European Union). RADAR-CNS involves 24 organizations in Europe and US, including CIBER through its thematic areas of Mental Health (CIBERSAM) and Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN)

“In recent years, the quality and quantity of data that can be collected with the wearable technology and smart phones has increased a lot. The information generated with this large amount of data will help to improve clinical care by providing greater detail of the patient’s condition and prognosis of its evolution. Moreover, it will be possible to detect whether a patient is beginning to have problems before there is clinical evidence of it” says Dr. Jordi Aguilo, scientific coordinator of the Unit 8 of NANBIOSIS.

This huge generate data sets, suitable to be stored and treated so to retrieve the relevant information hidden in the data, frequently require computing systems and information systems of high performance. The Unit 27 of NANBIOSIS will be the platform in which this analysis will be performed.

Pablo Laguna and Jordi Aguilo, Scientific Directors of the Units 27 and 8 of NANBIOSIS participate in the European program Remote Assessment
Read More

Graphene Flagship for Biomedical Tecnologies – Kick off meeting April 11-14 Barcelona

On April, 11-12 took place in Barcelona the kick off meeting of the new Graphene Flagship Work Package devoted to Biomedical Technologies, one emerging application area for graphene and other 2D materials. The Kick-off event, was co-organised by Dr. Rosa Villa (CNM-IMB-CSIC, CIBER-BBN) Scientific Coordinator of Unit 8 of NANBIOSIS (in the center of the first row in the photo). More than 35 Scientifics from 14 research groups attended to the meeting

The Graphene Flagship, the EU’s biggest ever research initiative, involves the coordination research of over 150 partners from more than 20 European countries withing a timeframe of 10 years. This project is implemented as a total of 15 research Work Packages on specific science and technology topics. The new Work Package will focus on the development of implants based on graphene and 2D-materials with therapeutic functionalities for specific clinical outcomes in neurology, ophthalmology and surgery, between other disciplines that will be further developed in the next phases of the Graphene Flagship.

The launch meeting held on 11 and 12 April in the Convalescence House of the Autonomous University of Barcelona (UAB), was co-organized by the ICN2, the National Microelectronics Centre (CNM-IMB-CSIC, CIBER-BBN; researcher Dr. CSIC. Villa Rosa) and IDIBAPS. This meeting began with two lectures given by well known neuroscientists, Dr. Gerardo Conesa, chief of neurosurgery at the Hospital del Mar (Barcelona) and Dr. Xavier Navarro,  the Institute of Neurosciences at the UAB and belonging to CIBERNED.

Nanbiosis_U8_Graphene Flagship for Biomedical Tecnologies
Read More

Elisabet Prats is a young scientist, researcher at Biomonitoring group of CIBER-BBN and  CNM, which coordinates Unit 8 of NANBIOSIS, and a science disseminator with comedian monologues at “Big Van”.

[Elisabet Prats in Informativos.net]

As a science disseminator, Elisabet has recently appeared in media and forums explaining the progress made by her research group in the European project Graphene Flagship. For example, a graphene sensor to detect brain electrical activity, successfully presented at Mobile World Congress. Elisabet clearly explains “We are able to measure the electrical signals of the brain with graphene, graphene due to its versatility, allows the reduction in size of the sensors, giving much more information to the doctor” and describes a future in which “we shall control mechanical arms with brains implants”.

Nanbiosis_U8 - Biomedical applications of graphene, Elisabet Prats in Informativos.net
Read More

The researcher Rosa Villa, Director of the Unit 8 of NANBIOSIS has developed this technology, in collaboration with other groups, within the framework of the project Graphene Flagship, the EU's biggest ever research initiative, in which CIBER-BBN participates.

These devices, that can detect the electrical activity of the brain, are currently being tested in animals by measuring their brain activity using  Graphene transitors and could have therapeutic applications, as well as allowing the design of new brain-machine interfaces.

Nanbiosis_Unit8-Graphene sensors presented in Mobile World Congress Barcelona 2016
Read More